Isabella Screpanti

Pubblicazioni

Titolo Pubblicato in Anno
Current trends in ATRA delivery for cancer therapy PHARMACEUTICS 2020
Notch3 targeting. A novel weapon against ovarian cancer stem cells STEM CELLS INTERNATIONAL 2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL FRONTIERS IN ONCOLOGY 2019
Chalcones and chalcone-mimetic derivatives as Notch inhibitors in a model of T-cell Acute Lymphoblastic Leukemia ACS MEDICINAL CHEMISTRY LETTERS 2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype JOURNAL OF ONCOLOGY 2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer FRONTIERS IN GENETICS 2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance CANCER RESEARCH 2019
Interplay of protein corona and immune cells controls blood residency of liposomes NATURE COMMUNICATIONS 2019
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION 2019
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application The XI Notch meeting 2019
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer NEW TECHNOLOGIES TO FIGHT CANCER 2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression THE JOURNAL OF BIOLOGICAL CHEMISTRY 2019
Hypotonic, acidic oxidizing solution containing hypochlorous acid (HClO) as a potential treatment of hailey-hailey disease MOLECULES 2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response The Biennial Congress of the Italian Association of cell biology and differentiation 2019
Broadening phenotype of adenylosuccinate lyase deficiency: A novel clinical pattern resembling neuronal ceroid lipofuscinosis MOLECULAR GENETICS AND METABOLISM REPORTS 2019
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis NATURE COMMUNICATIONS 2018
A non-conserved amino acid variant regulates differential signalling between human and mouse CD28 NATURE COMMUNICATIONS 2018
Notch signaling as a therapeutic target for acute lymphoblastic leukemia EXPERT OPINION ON THERAPEUTIC TARGETS 2018
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Atti del ABCD - PPh.D. meeting 2018
Targeting the ER/UPR signalling in Notch3-overexpressing T-cell acute lymphoblastic leukemia. Atti del ABCD - Ph.D. meeting 2018

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma